Clinical Trial Update: Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating linagliptin for safety and efficacy in adults with type 2 diabetes mellitus and moderate to severe renal impairment; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Linagliptin (linagliptin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2013-10-17